Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2).

Sujoy GhoshMangesh TiwaskarRajiv ChawlaShalini JaggiArthur AsirvathamVijay Panikar

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2020)

Teneligliptin significantly improved glycaemic parameters in Indian patients with T2DM when prescribed either as monotherapy or as an add-on to one or more other commonly prescribed antihyperglycaemic agents.

Keyphrases

type diabetes
randomized controlled trial
combination therapy
open label
clinical trial
skeletal muscle
insulin resistance